Evidence Hub

47 pneumocystis jirovecii pneumonia prophylaxis in patients with glioma receiving concurrent chemoradiation: a systematic review

Jason L. Jia, A. Beltran-Bless, Bader Alshamsan, Megan MacRae, Foster Rose, Jennifer Leigh, Deepro Chowdhury, F. Fazzari et al.

Neuro-Oncology Advances, 2025

11,810 participants · 1 citation

Abstract

Abstract BACKGROUND Routine antibiotic prophylaxis against pneumocystis jirovecii pneumonia (PJP) is mandated during concurrent temozolomide and radiation therapy (TMZ-RT) based on early studies in patients with glioma. However, the true risk of PJP in this population may have been overestimated and calls into question the value of routine prophylaxis in this population considering the possible harms. METHODS A systematic search was conducted in MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials from inception up until Jan 2024. Eligible articles were randomized controlled trials, prospective and retrospective cohort studies, and chart reviews of glioma patients treated with TMZ-RT, with or without PJP prophylaxis, with PJP incidence as a reported outcome. Study outcomes included overall PJP incidence, and PJP incidence based on prophylaxis use, corticosteroid exposure, and lymphopenia. FINDINGS A total of 28 out of 3,003 initially identified studies were included in this review. Of the combined 11,810 glioma patients, 11,077 received TMZ-RT. The incidence of PJP cases amongst all TMZ-RT patients was 0·7% (71/10,118). Seven out of 28 studies recorded PJP prophylaxis use, including five prospective and two retrospective designs. From these studies, we determined PJP incidence amongst subgroups with and without prophylaxis to be 0·8% (14/1,765) and 0·3% (9/2,719), respectively. Corticosteroid exposure was recorded in a median of 56·5% (range: 27·3% to 89·0%)…

How strong is the evidence?

Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 11,810 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free